PLSE
Pulse Biosciences, Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$28.96+0.98%
Price as of Jul 20, 2026
PLSE growth
Pulse Biosciences, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- —
- EBITDA
- -20.9%
- EBIT
- -22.5%
- EPS
- -10.1%
- Free cash flow
- -37.9%
- Operating cash flow
- -37.7%
Forward estimates
- Revenue
- +860.4%
- EBITDA
- +98.1%
- EPS
- -34.9%
Three-year CAGR
- Revenue
- -20.6%
- EBITDA
- -36.8%
- EBIT
- -36.8%
- Net income
- -35.8%
- EPS
- -17.4%
- Free cash flow
- -49.3%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.